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Murine P19 embryonal carcinoma (EC) cells are convenient to differentiate into all germ layer derivatives.
One of the advantages of P19 cells is that the exogenous DNA can be easily inserted into them. Here, at
the ﬁrst part of this study, we generated stable GFP-expressing P19 cells (P19-GFPþ). FACS and western-
blot analysis conﬁrmed stable expression of GFP in the cells. We previously demonstrated the efﬁcient
induction of neuronal differentiation from mouse ES and EC cells by application of a neuroprotective
drug, selegiline In the second part of this study selegiline was used to induce differentiation of P19-GFPþ
into stable GFP-expressing neuron-like cells. Cresyl violet staining conﬁrmed neuronal morphology of the
differentiated cells. Furthermore, real-time PCR and immunoﬂourescence approved the expression of
neuron speciﬁc markers. P19-GFPþ cells were able to survive, migrate and integrated into host tissues
when transplanted to developing chick embryo CNS. The obtained live GFP-expressing cells can be used
as an abundant source of developmentally pluripotent material for transplantation studies, investigating
the cellular and molecular aspects of early differentiation.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Embryonic stem (ES) and embryonal carcinoma (EC) cells are
pluripotent cells which can differentiate into all the germ layer
derivatives. Examples of undifferentiated EC cell lines are the hu-
man Tera-2 [1], and mouse F9 [2] and P19 EC cells [3]. Similar to the
other EC cells, P19 is immortal and rapidly proliferates in culture
[4]. On non-adherent surfaces the EC cells stick to each other and
form small aggregates, embryoid bodies (EBs). Non-toxic concen-
trations of some drugs can be added easily to P19 cultures to inducehirzad), f.smaeili@sci.ui.ac.ir
Bakhshalizadeh), ebrahimi.
il.ebrahimie@adelaide.edu.auefﬁcient differentiation of the cells. The most effective drugs in
differentiation induction of P19 cells are retinoic acid (RA) [5] and
dimethyl sulfoxide (DMSO) [6]. Our previous studies showed that
neural differentiation of a mouse ES line (CCE) and P19 EC cells can
be efﬁciently induced by a pharmacological neuroprotective drug,
selegiline (deprenyl) [7,8]. Selegiline is a good candidate in treat-
ment of neurotoxicity which is used clinically in Parkinson's disease
[9].
One of the major advantages of P19 cells is that they are excel-
lent recipients of DNA transfected by calcium phosphate or elec-
troporation procedures [3]. Green ﬂuorescent protein (GFP) as a
reporter gene encodes a non-toxic protein [10,11]. This protein
exhibits intrinsic ﬂuorescence, does not dependent on cofactors or
substrates and can be utilized in a variety of species [12,13]. A
mutant version of GFP, enhanced GFP (eGFP) is optimized for mi-
croscopy and ﬂow cytometry detection [14]. Labeling stem cells
Table 1
Real time PCR Primer Sequences.
Gene Primer sequences Genbank accession
Nestin F: 50-TCCGGGCCCCTGAAGTCGAG-30 NM_016701
R: 50-CCAGGGCTTCCACAGCCAGC-30
Synaptophysin F: 50-CATTCATGCGCGCACCTCCA-30 NM_009305
R: 50-TTGCTGCCCATAGTCGCCCT-30
Oct3/4 F: 50-TTTCTGAAGTGCCCGAAGCCCT-30 NC_000083
R: 50-TTCCATAGCCTGGGGTGCCAAA-3
b-2M F: 50-AGTCGTCAGCATGGCTCGCT-30 NM_009735
R: 50-TGAGGCGGGTGGAACTGTGT-30
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important applications in basic researches and stem cell biology
[15,16].
In this study, we generated stably transfected P19 cells (P19-
GFPþ) with a vector containing eGFP. Selegiline was then used to
induce cell differentiation into stable GFP-expressing neuron-like
cells. Finally, to investigate cell ability to survive, migrate, inte-
grate and differentiate in host tissues, the selegiline treated P19-
GFPþ cells were transplanted to the developing chick embryo
central nervous system (CNS).
2. Materials and methods
2.1. Plasmids
The following plasmids were used: pML8 (encods puromycin
resistance gene and eGFP under Pgk-1 promoter control) and pB17
(containing a fragment of pgk-1 gene). All plasmids were kindly
donated by Dr. McBurney's laboratory (Ottawa Regional Cancer
Center, Ottawa, Canada).
2.2. Culture of P19 cells and their transfection
P19 cells were plated at concentration of 1.5  106 count and
transfected with 5 mg of circular plasmid by calcium phosphate
(CaPO4) co-precipitation method [17]. Brieﬂy, the cells were
expanded 24 h before transfection and solution of CaPO4eDNAwas
added dropwise onto them. They were incubated for 7e9 h at 37 C
in 5% CO2 and then the growth medium was replaced by fresh a-
MEM (Minimum Essential Medium, Gibco-BRL, Carlsbad, CA,
11900073). A medium containing 2 mg/ml puromycin (puro) was
used for stable transfection. After 8 days post transfection, indi-
vidual GFPþ colonies were picked and expanded for more than 6
month (mo). Fluorescent intensity was visualized by ﬂuorescence
microscopy in living P19-GFPþcells, 8 days post transfection.
2.3. Hematoxylin and eosin staining
The adherent cells were ﬁxed, rehydrated and rinsed in PBS.
They were then incubated in hematoxylin for 15 min and coun-
terstained in 1% Eosin for 30 s. The cells were dehydrated and
cleared in Xylene and ﬁnally mounted for bright light imaging.
2.4. Fluorescent-activated cell sorting (FACS) of P19-GFP expressing
cells
For ﬂow cytometry, suspension of single cells was prepared to
analyze GFP expression, directly. Untransfected cells were used to
adjust detector settings. Fluorescent intensity determination was
performed on FACS (LSR, Becton Dickenson) with 10,000 events per
sample. The cells were gated for GFPþ signals. The data acquisition
and analysis were carried out with CELLQUEST software (Becton
Dickenson, USA).
2.5. Western-blot of GFP protein in P19 cells
Protein concentration of the cell extracts was determined ac-
cording to the Bradford (DC Protein Assay; Bio-Rad, Canada). Equal
amounts of protein were transferred to nitrocellulose membranes
and then blocked and incubated with anti-GFP antibody (rabbit
anti-GFP antibody, dilution 1/2000, Sigma, G1544, USA). Detection
of secondary antibody was carried out using goat anti-rabbit
horseradish peroxidase (HRP)-conjugated (Santa Cruz, USA). The
membranes were ﬁnally exposed to X-ray ﬁlm (Kodak MR-1) in a
range of 30 s to 5 min.2.6. Neuronal induction of P19-GFPþcells
Undifferentiated stable P19-GFPþ cells were dissociated and
cultured in 20 ml hanging drops to produce EBs. The resulting EBs
were then cultured in a-MEM supplemented by 3% fetal bovine
serum (FBS, Gibco, 10270-106). To induce neuronal lineage differ-
entiation of EBs discrete concentration of selegiline (108 M, Zah-
ravi Pharmaceutical Company, Tabriz, Iran) was applied [7,8].
2.7. Cresyl violet staining
The adherent cells were ﬁxed, dehydrated, washed and then
incubated in stain solution (0.25% cresyl violet, 0.8% glacial acetic
acid, 0.6 mM sodium acetate) [18] for 3e10 min. The stained cells
were washed and then mounted for examination.
2.8. Real-time polymerase chain reaction
Pluripotency stem cell marker, Oct3/4 (POU class 5 homeobox
1), as well as neuroepithelial (nestin) and neural speciﬁc (syn-
aptophysin) markers, were evaluated by QPCR. Total RNA was
extracted from the cells using Qiazol lysis reagent (Qiagen, 79306).
cDNA synthesis was carried out by PrimeScript™ RT reagent Kit
(Takara cDNA kit, RR037A_e.v1112Da) using SYBR Premix Ex Taq
(TaKaRa, RR081Q) and speciﬁc primers (Table 1). To perform
RTePCR assays StepOnePlus™ Real-Time PCR System was used. RT
samples, negative controls (no primers or no template) and b-2
microglobulin (b-2M, as housekeeping gene) were run together. To
analyze the PCR reaction efﬁciency for each gene tested, standard
curves were used. A melt-curve analysis was performed at the end
of each reaction. Expression levels were normalized to individual b-
2M (as internal control). The proﬁle was obtained by plotting
relative gene expression levels comparing to undifferentiated P19
EC cells.
For statistical analysis the differences between the mean values
were compared using Student's t-test for two groups and one-way
analysis of variance (ANOVA) and Duncan's Test for more than two
groups. Results are reported as mean ± SD (standard deviation) and
p < 0.05 was considered to be statistically signiﬁcant.
2.9. In ovo surgery and cell transplantation
Fertile White Leghorn chick eggs were provided from a local
supplier (Zagros, Shahrekord, Iran) and incubated at 38 C in a
humidiﬁed incubator for about three days. Staging of the embryos
were carried out according to Hamburger and Hamilton [19]. Under
sterile conditions, a window was made in the egg shell. About
200 cells were transplanted into the brain vesicle of chick embryos
at stage 18e20. The eggs were sealed and then incubated for
additional 1e3 days. At the appropriate time the chick embryos
were ﬁxed, dehydrated in ethanol and embedded in parafﬁn. Five
mm parasagital sections were prepared and double stained with
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2.10. Immunoﬂourescence
The primary antibodies including mouse anti-synaptophysin
monoclonal antibody (Abcam, San Francisco, CA, ab8049), mouse
anti b-III tubulin monoclonal antibody (Abcam, Cambridge, USA,
ab7751) and rabbit polyclonal antibody to GFP (Abcam, Cambridge,
USA, ab290) were used in this study. FITC-conjugatedanti-mouse
IgG (Sigma, St. Louis, MO, F9137) and Cy5.29-conjugated anti-
rabbit IgG (Abcam, Cambridge, USA, ab6564) were used as sec-
ondary antibodies. The cells were cultured on cover slip in 12-well
plates, ﬁxed and permeabilized with 0.2e0.3% Triton X-100 in PBS.
To block nonspeciﬁc binding, the cells were then incubated with
10% NGS (normal goat serum, Sigma, G9023). For double labeling
ﬂuorescent, the cells were incubated with two primary antibodies
together, for 60 min (anti-GFP and anti-synaptophysin, or anti-GFP
and anti b-III tubulin) and then with the relevant secondary anti-
bodies for 30 min. Several groups with no primary antibodies were
considered as controls. Parafﬁn-embedded sections of chicken
embryos were dewaxed, rehydrated, and washed. To quench
endogenous formalin-related ﬂuorescence, the slides were incu-
bated in 2% sodium borohydride (Sigma, S9125) and 0.1 M glycine
[20]. Antigen retrieval was performed enzymatically. Nuclei are
counterstained by Hoechst for 5e10 min at room temperature.
3. Results
3.1. Stable transfection of eGFP gene
At the ﬁrst part of this study undifferentiated P19 cells wereFig. 1. Fluorescent intensity of undifferentiated P19-GFPþ cells was demonstrated by ﬂuore
pB17. A: An individual colony with high GFP expression, subjected to puro selection 48 h pos
differentiation induction. D is hematoxylin-eosin staining of the same ﬁeld shown in C. Tight
cells.transfected with pML8 and pB17 vectors. 48 h post transfection the
cells were subjected to puro selection and expanded for 8 more
days before analysis. Fluorescent intensity of eGFPþ cells was
detected under viable conditions by ﬂuorescence microscopy, eight
days post transfection (Fig.1). The individual colonies with high GFP
expression (Fig. 1A) were picked and expanded for at least 8 days
before differentiation induction (Fig. 1B and C). The microscopic
patterns of GFP expression were quantitatively assessed by FACS.
Suspensions of single cells were prepared from the untransfected
and transfected cells and subjected to FACS for determination of
eGFP intensity. FACS analysis of pooled stable cells indicated that
82.87% of the cells were eGFPþ (Fig. 2B), while only 0.56% were
positive in the untransfected cells (Fig. 2A).
To conﬁrm the ﬁnding of eGFP expression in living EC cells, we
performed western-blot experiments using anti-GFP antibody
(Fig. 2C). The results indicated sufﬁcient expression of eGFP in
transfected P19 cells. No eGFP protein was detected in untrans-
fected cells.
3.2. Neuronal differentiation of stable P19-GFPþ cells by selegiline
Based on our previous studies, the best selegiline concentration
for neural induction of ES and P19 cells is 108 M [7,8]. Therefore,
this concentration of the drug was used to induce neural differ-
entiation of P19-GFPþ-derived EBs. Selegiline-treated EBs were
plated and then allowed to attach on gelatin-coated dishes to form
outgrowth of neuron-like cells. Fig. 3 represents the morphology of
the differentiated P19-GFPþ cells. The cells were cultured and
expanded at undifferentiated state (Fig. 3A) and then subjected to
suspension cuture to produce EBs (Fig. 3B). Proliferative cells
expand around the EBs and form a monolayer of cells (Fig. 3BeD).scence microscopy at 8 days post-transfection, in the cells transfected with pML8 and
t-transfection. B & C: The colonies were picked and expanded for at least 8 days before
ly packed polygonal cells with high nucleus/cytoplasm ratio, represent undifferentiated
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morphology of neuronal cells (Fig. 3C and D). Aggregates of neurons
have been formed with areas of lower density of neural cell bodies
in between. The aggregates are interconnected by ﬁne processes
(arrowheads). Cresyl violet staining of the differentiated cell indi-
cated that neuronal cells formed cellular networks on top of the cell
monolayer (Fig. 3E and F). Fig. 3G shows P19-GFPþ-derived neurons
under viable conditions by ﬂuorescence microscopy after about
6 mo post transfection. Panel H is a bright ﬁeld of the same image
shown in panel G. Although, no quantitative analysis was carried
out, overall, our observations showed that many of the differenti-
ated GFPþ cells had morphology of neural cells, as well as complex
patterns of branches.
Co-expression of neuronal markers and GFP in P19-derived
neuron-like cells was analyzed using double immunoﬂuorescence
(Fig. 4). Expression of neuronal speciﬁcmarkers, synaptophysin and
b-III tubulin were examined using speciﬁc antibodies, to charac-
terize post-mitotic mature neurons. Immunoﬂourescence of the
differentiated P19-GFPþcells showed that they were immunoreac-
tive to b-III tubulin (Fig. 4AeD) and synaptophysin (Fig. 4EeH),
after selegiline treatment. This Figure highlights many cells that co-
express both GFP (B) and b-III tubulin (C) or GFP (F) and synapto-
physin (G). Panels A and E are the bright ﬁeld of the same images
shown in B and F respectively. Merged images of GFP and b-III
tubulin (D) and GFP and synaptophysin (H) are also presented.
Data analysis of real-time PCR revealed that the differentiated
cells expressed neuroepithelial and neural speciﬁc markers, nestinFig. 2. GFP expression in undifferentiated P19 EC cells. A and B show FACS analysis of EC cel
The cells transfected with pML8 and pB17. The peak pattern represents ﬂuorescent proﬁle o
reﬂects the positive cell percentage. C: Analysis of eGFP protein (MW: 27.5 kDa) expressio
untrans: untransfected P19 cells, trans: transfected P19 cells with pML8 and pB17.and synaptophysin (Fig. 5). Expression of nestin by selegiline-
treated cells (211.6805) was signiﬁcantly higher than that of P19
and RA (10.57669) groups (Fig. 5A). Synatophysin gene expression
in these cells (147.8221) was also more than that of all the other
groups (RA: 28.42384, B: 59.47915) (Fig. 5B). The difference was
signiﬁcant. Furtheremore, the proliferative marker of stem cells,
Oct3/4 showed signiﬁcant reduction in the differentiated cells
(Fig. 5C).3.3. In ovo transplantation of P19-GFPþcells
To investigate the ability of selegiline treated P19-GFPþcells to
survive, differentiate, and migrate into central nervous system, the
cells were transplanted into the brain vesicle of 3-days-old chick
embryos (Fig. 6A). A clump of GFP-expressing cells is visible clearly
in the living embryo, at the time of cell injection (Fig. 6B). Fluo-
rescence analysis of whole chick embryos injected with P19-
GFPþcells, illustrated that the cells were capable of surviving in
the embryos (Fig. 6C). By 3e5 days after transplantation, GFP-
expressing cells migrated to the regions distant from the implan-
tation site, in the host embryo. Fig. 6C shows that the cells migrated
away from the transplantation site and could integrate into the
surrounding tissues such as visceral arches, brain vesicles and
neural tube. In ovo transplanted cells survived and underwent
morphologic differentiation reminiscent of neurons (Fig. 7). Anti-
bodies against neuronal speciﬁc markers and anti-GFP antibody
were used simultaneously to determine whether the transplantedls 8 d after initial puro selection at 48 h post-transfection. A: Untransfected P19 cells. B:
f the cells. The gated region for positive eGFP cells is indicated by the bar. The number
n in P19 cells, by western-blot. GFP was detected with anti-GFP antibody. M: marker,
Fig. 3. Photomicrographs of undifferentiated and differentiated P19-GFPþ cells into
neuronal phenotype. A: An undifferentiated P19 clamp and C: A P19-derived EB before
selegiline treatment. B and D: After about 2 wk, the selegiline-treated cells showed
characteristic morphology of neuronal cells (soma and neurites). Aggregates of neu-
rons have been formed with areas of lower density of neural cell bodies in between.
The aggregates are interconnected by ﬁne processes. Cresyl violet was used to stain the
differentiated neurons. E & F: Neuronal-like cells (arrow) formed a cellular network on
top of the monolayer. The arrowheads indicate the neuronal extension. The asterisk
indicates a non-neuronal cell with distinctive nucleus and nucleolus (arrowhead). G.
Fluorescence micrographs illustrating GFP expression in living neuronal-like cells
derived from P19-GFPþ cells after selegiline treatment. H is a bright ﬁeld of the same
image shown in G. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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ronment of the chick embryo. We found that the donor cells
differentiated in ovo, with morphological and molecular charac-
teristics of neurons. In the neural tube, the migrating cells formed a
continuous layer (Fig. 7 arrowheads). A subpopulation of these cells
was clearly found to co-express both GFP and b-III tubulin (Fig. 7A)
or GFP and synaptophysin (Fig. 7B). Nuclei are counterstained by
Hoechst. Beside GFP expression, donor cells are easily identiﬁable
from host cells due to denser heterochromatic masses and larger
nuclei. Distinct clusters of transplanted cells are visible with the
positive response to speciﬁc marker of differentiating neurons, b-III
tubulin (Fig. 7A, arrows). Synaptophysin-expressing donor cells are
apparently intermingled with host tissues (Fig. 7B, arrows).
4. Discussion
In the present study, differentiation of stable GFPþ cells was
veriﬁed in vivo by in ovo transplantation to developing CNS of chick
embryos at stage 18e20. First of all, by utilizing P19 EC cell line and
vectors containing eGFP gene and pgk-1 promoter, we indicated the
possibility of production of stable GFP-expressing cells, in vitro. GFP
expression of P19 cells was observed by ﬂuorescence microscopy,
and then conﬁrmed by western blots and FACS analysis. Addition-
ally, P19-GFPþ cells were successfully differentiated into neural
cells by selegiline drug, as an inducer. The differentiated GFPþ cells
obtained in this culture indicated typical morphology of neuron
and exhibited a number of neuronal speciﬁc markers such as syn-
aptophysin and b-III tubulin. Cultures of GFPþ-P19 cells and GFPþ
neuronal cells continued for more than 6 mo. To investigate the
ability of selegiline treated P19-GFPþcells to maintain survival,
differentiate, and migrate in CNS, they were transplanted into the
brain vesicle of chick embryos. Our data indicated that by 3e5 days
after transplantation the cells migrated away from the trans-
plantation site and could integrate into the surrounding host tis-
sues such as brain vesicles, visceral arches, and neural tube.
A number of studies have reported GFP expression by P19 cells
[21,22]. In the previous studies, these cells were transfected with a
construct containing murine Tert promoter (mTert: reverse tran-
scriptase component of murine telomerase) combined with GFP
gene. Down-regulation of mTert_GFP expression during differen-
tiation was observed as a result of RA application [22]. Kim et al.
(2001) transfected P19 cells with the gene for GFP under the control
of the neuronal T_1 tubulin promoter. After four days of treatment
with RA, GFPwas speciﬁcally detected in cells undergoing neuronal
differentiation [21].
P19 EC line provides an excellent model to investigate regulation
of neuronal differentiation and development. These cells are highly
available and usually do not require feeders and/or special growth
conditions. Interestingly, they can be induced to differentiate by
simple manipulation of the culture conditions [3]. Finally, P19 EC
cells are suitable for genetic manipulations such as transfection and
establishment of stable cell lines expressing inserted genes [23].
The stable expression of reporter genes has excellent applications
in cell biology [15]. In the current study, P19 EC cells were stably
transfected by a construct containing eGFP. To obtain stable cell
population, puro was used and the individual GFPþ colonies were
picked and expanded. Culture of P19-GFPþ EC cells continued for
more than 6 mo. These cells were successfully freezed and thawed
for several times. In linewith previous studies [24,25], the results of
this report showed that it is possible to produce long-term GFP-
expressing cells. Stable gene expression is an indicator of successful
gene transfection and insertion [15]. Taghizadeh et al. (2008) were
able to get transient GFP-expressing cells for up to 72e96 h post-
transfection, but they were unable to extend these clones as
long-term, stable GFP-expressing cells [15]. Other researchers haveobtained similar results by using different GFP-expressing vectors
[26,27]. Recently, Mii et al. (2013) demonstrated that ND-GFP cells,
nestin-expressing cells from transgenic mice were able to differ-
entiate into neurons, glia, keratinocytes, and smooth muscle cells
in vitro [25]. Since, GFP encodes a non-toxic marker [28] and
P19 cells are excellent recipients of foreign DNA [3], the difference
between our results and those of the others may be due to different
Fig. 4. Fluorescence micrographs illustrating the co-expression of GFP and speciﬁc neuronal markers in neuronal-like cells derived from P19-GFPþ cells after differentiation in-
duction. Stable P19-GFPþ cells treated with selegiline show immunoreactivity for both GFP (B) and b-III tubulin (C), a classic marker for differentiating neurons, and both GFP (F) and
synaptophysin (G), a reliable marker of nerve terminal differentiation. Synaptophysin concentrated in a brightly ﬂuorescent spot (arrow). A and E are the bright ﬁeld of the same
images shown in B and F respectively. D: Merged image of GFP and b-III tubulin. H. Merged image of GFP and synaptophysin.
Fig. 5. Relative expression of neuroepithelial gene, nestin (A), neural speciﬁc gene, synaptophysin (B) and proliferative marker of stem cells, Oct3/4 (C). P19: untreated cells, S:
selegiline-treated cells, RA: retinoic acid-treated cells, B: neonatal brain tissue.
Fig. 6. In ovo transplantation of P19-GFPþcells. Representative micrograph shows: A: A chick embryo in stage 19 (68e72 h) according to Hamburger and Hamilton. B: A clump of
GFP-expressing cells, transplanted into the brain vesicle of 3-days-old chick embryos (arrow). The embryo was photographed in situ. C: By 3e5 days after transplantation, GFP-
expressing cells migrated to surrounding tissues such as brain vesicles, neural tube and visceral arches (arrows).
H. Shirzad et al. / Molecular and Cellular Probes 32 (2017) 46e54 51transfection protocols, as well as using different stem cell lines.
Furthermore, co-transfection of pB17 plasmid with exogenousexpression plasmids greatly enhances the levels of transcript ob-
tained from foreign DNA sequences. pB17 plasmid has a fragment of
Fig. 7. Double immunoﬂuorescent stainings of P19-GFPþcells differentiated in ovo. Five mm parasagital sections were prepared and double stained with antibodies against neuronal
markers and GFP. Stable P19-GFPþ cells treated with selegiline show immunoreactivity for both (A) GFP and b-III tubulin and (B) GFP and synaptophysin. Nuclei are counterstained
by Hoechst. In the neural tube the migrating cells formed a continuous layer (upper rows, arrowheads). Beside GFP expression, donor cells are easily identiﬁable from host cells due
to denser heterochromatic masses and larger nuclei. Distinct clusters of transplanted cells are visible with the positive response to speciﬁc marker of differentiating neurons, b-III
tubulin (A, lower rows, arrows). Synaptophysin-expressing donor cells are apparently intermingled with host tissues (B, lower rows, arrows). Asterisk point to optic vesicle in A and
visceral arch and cleft in B.
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greatly [29]. Therefore, pB17 was included in all transfections, in
the present study. This effect of pB17 is cell speciﬁc and occurs only
in EC cells. Reporter genes can be used to purify populations of cells
by FACS and to trace cells after transplantation [30,31]. The GFP
genewas selected in the present study, because: 1) GFP is a reporter
gene that encodes a non-toxic marker [28], 2) it is the most studied
reporter gene and highly used in cellular and molecular biology
[32], 3) it can be utilized in a variety of species [12,13,15], and mostimportantly, 4) the major advantage of GFP is its ability to exhibit
endogenous ﬂuorescence; a cofactor is needed for most ﬂuorescent
proteins [33].
Neuronal differentiation of P19 cells was previously reported
[8,34,35]. In addition, the neuronal cells derived from P19 have
been successfully applied in several transplantation studies [36].
Here, in the present study, we proposed a simple and efﬁcient
strategy for neuronal differentiation studies both in vitro and
in vivo. As a basis for the next experiments, we ﬁrst examined
H. Shirzad et al. / Molecular and Cellular Probes 32 (2017) 46e54 53whether the GFP-expressing cells also differentiate into a neural
phenotype after treatment by a neuroprotective pharmacological
drug, selegiline. Then the differentiated GFPþ cells were utilized in
transplantation studies of our experiments. We shouldmore realize
the mechanisms of stem cell action and know how to control of
stem cell survival, migration, proliferation and differentiation, post-
transplantation [37]. Our results indicated that in ovo transplanted
GFPþ cells were able to survive, differentiate, migrate and integrate
with host tissues. It is possible that the embryonic environment of
the host could induce their differentiation. The chick embryo is able
to serve as a unique and accessible experimental system for the
investigation of inductive differentiation and interactions in
development. The feasibility of labeling stem cells by GFP before
transplantation has important and promising perspectives for their
use in the future basic researches [16].
5. Conclusion
In the present study, using P19 EC cell line, stable and long-
lasting GFP-expressing cells was made and characterized.
Neuronal differentiation of these cells was induced by a neuro-
protective drug, selegiline (deprenyl). Many of the differentiated
GFP-expressing cells had key characteristics of neurons. In addition,
we showed that in ovo grafted P19-GFPþ cells not only survived, but
also migrated away from the transplantation site and differentiated
into the cells with molecular characteristics of neurons. These
neuron-like cells were apparently intermingled with host tissues.
The chick embryo can be used as a unique and accessible experi-
mental system for in vivo studies of stem cell development.
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